AtriCure Statistics
Total Valuation
AtriCure has a market cap or net worth of $1.50 billion. The enterprise value is $1.44 billion.
Important Dates
The next estimated earnings date is Thursday, February 13, 2025, after market close.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AtriCure has 48.75 million shares outstanding. The number of shares has increased by 1.35% in one year.
| Current Share Class | 48.75M |
| Shares Outstanding | 48.75M |
| Shares Change (YoY) | +1.35% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 3.40% |
| Owned by Institutions (%) | 102.55% |
| Float | 47.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.21 |
| Forward PS | 2.90 |
| PB Ratio | 3.22 |
| P/TBV Ratio | 8.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 144.04 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.62 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.06 |
Financial Efficiency
Return on equity (ROE) is -8.39% and return on invested capital (ROIC) is -3.96%.
| Return on Equity (ROE) | -8.39% |
| Return on Assets (ROA) | -3.51% |
| Return on Capital (ROIC) | -3.96% |
| Revenue Per Employee | $372,978 |
| Profits Per Employee | -$32,433 |
| Employee Count | 1,200 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.63 |
Taxes
In the past 12 months, AtriCure has paid $1.13 million in taxes.
| Income Tax | 1.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.36% in the last 52 weeks. The beta is 1.40, so AtriCure's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -14.36% |
| 50-Day Moving Average | 33.12 |
| 200-Day Moving Average | 26.92 |
| Relative Strength Index (RSI) | 34.24 |
| Average Volume (20 Days) | 412,350 |
Short Selling Information
The latest short interest is 1.69 million, so 3.47% of the outstanding shares have been sold short.
| Short Interest | 1.69M |
| Short Previous Month | 1.67M |
| Short % of Shares Out | 3.47% |
| Short % of Float | 3.59% |
| Short Ratio (days to cover) | 2.59 |
Income Statement
In the last 12 months, AtriCure had revenue of $447.57 million and -$38.92 million in losses. Loss per share was -$0.83.
| Revenue | 447.57M |
| Gross Profit | 334.72M |
| Operating Income | -34.16M |
| Pretax Income | -39.27M |
| Net Income | -38.92M |
| EBITDA | -16.07M |
| EBIT | -34.16M |
| Loss Per Share | -$0.83 |
Full Income StatementBalance Sheet
The company has $130.34 million in cash and $77.13 million in debt, giving a net cash position of $53.21 million or $1.09 per share.
| Cash & Cash Equivalents | 130.34M |
| Total Debt | 77.13M |
| Net Cash | 53.21M |
| Net Cash Per Share | $1.09 |
| Equity (Book Value) | 465.02M |
| Book Value Per Share | 9.54 |
| Working Capital | 194.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $10.40 million and capital expenditures -$11.55 million, giving a free cash flow of -$1.15 million.
| Operating Cash Flow | 10.40M |
| Capital Expenditures | -11.55M |
| Free Cash Flow | -1.15M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 74.79%, with operating and profit margins of -7.63% and -8.70%.
| Gross Margin | 74.79% |
| Operating Margin | -7.63% |
| Pretax Margin | -8.44% |
| Profit Margin | -8.70% |
| EBITDA Margin | -3.59% |
| EBIT Margin | -7.63% |
| FCF Margin | n/a |
Dividends & Yields
AtriCure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.35% |
| Shareholder Yield | -1.35% |
| Earnings Yield | -2.60% |
| FCF Yield | -0.08% |
Dividend DetailsAnalyst Forecast
The average price target for AtriCure is $41.78, which is 36.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.78 |
| Price Target Difference | 36.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 17.21% |
| EPS Growth Forecast (5Y) | -12.52% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AtriCure has an Altman Z-Score of 5.7 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.7 |
| Piotroski F-Score | 4 |